A centerpiece of the federal reform law, now almost ten years old, was to create insurance exchange marketplaces where individuals who otherwise couldn’t find health insurance, and who were now mandated to get it, could buy policies. The theory was that insurers would just be so eager to compete for these new customers and premiums were promised to be lower and stay low. Of course, none of that happened, as several prominent critics had pointed out would likely be the case. The plans participating on the exchanges are required to provide periodic data on denials of claims and appeals from those denials. The Kaiser family foundation did a summary of this information from 2015 to 2017 on the federal exchanges. (KFF Report) There were 180 insurers in those exchanges, of those 130 reported complete data. According to Kaiser’s analysis of the data, 19% of in-network claims were denied in 2017, with a very wide range of from less than 1% to 40%. You have to wonder what is going on with those high rates, and you wonder even more when less than 1/2 of one percent of those denials were appealed and 14% of appeals resulted in overturning the denial. Forty of the 130 reporting plans had a denial rate of 10% or less, and 47 denied more than 20% of in-network claims. And if these statistics are at all accurate for in-network claims, what is happening with out-of-network ones, which typically see much higher denial rates. But as Kaiser notes, there is no explanation of why a claim was denied in the data and it is very possible insurers aren’t even using common definitions of what a denial is. For example, it is very common for providers to file a claim without all the information needed or required on the claim form. That is not really a denial. Duplicate claim filing by providers is also a common occurrence. I suspect many of the denials are because the person wasn’t actually covered by the insurer–they never paid their premium, or otherwise lost or never had eligibility. What would be more useful data is how many claims are denied for lack of medical necessity or other supposed clinical reasons; that would help you understand the extent to which plans were just trying to dodge legitimate obligations. So while the headline seems alarming, I suspect the reality, while not great for consumers, is much better.
Exchange Policy Claim Denials
By Kevin RocheMarch 5, 2019Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
March 27, 2023
Why You Can’t Trust People Who Make Up Stuff About Vax Safety
A couple of studies offer a far better explanation for heart issues in athletes and…
March 25, 2023
Coronamonomania Lives Forever, Part 201
Tired of March Madness? A boringly refreshing dip into some CV-19 research summaries is recommended.
March 24, 2023
The CDC Is a Font of Methodological and Statistical Error
Several times in the last three years I and others have pointed out serious flaws…